1 min read · 23 December 2009
1 min read · 23 December 2009
LifeSync Holdings Inc. has purchased the Besson wireless patent portfolio from Motorola Inc. No financial terms were disclosed. The patents cover "wireless, two-way, digital communication between patient-electrodes or sensors and an evaluator station for monitoring a patient." LifeSync is a subsidiary of GMP Companies, whose investors include Affinity Capital Management, TPG Captial and VCE Capital.
1 min read · 23 December 2009
Webvanta Inc., a Sebastopol, Calif.-based developer of SaaS solutions for building content-rich websites, has closed its Series A funding led by individuals from the North Bay Angels. No financial terms were disclosed, although the two-year-old company recently reported in a regulatory filing that it had secured $378,000 of a $500,000 equity offering.
1 min read · 23 December 2009
PTC Therapeutics Inc., a South Plainfield, N.J.-based drug company focused on post-transcriptional control mechanisms, has raised $50 million in new VC funding. The Column Group and return backer Delphi Ventures co-led the round. Undisclosed new investors were joined by return backers like CSFB Private Equity, HBM BioVentures, Novo A/S and Celgene. PTC previously raised over $143 million in VC funding, and filed for an IPO in 2006 that it later withdrew.
2 min read · 23 December 2009
Rho Ventures has agreed to purchase $15 million worth of newly-issued common stock in Bluefly Inc. (Nasdaq: BFLY), an online fashion retailer.
4 min read · 22 December 2009
1 min read · 22 December 2009
Deltagen Inc. (OTC BB: DGEN) has acquired Benten BioServices Inc., a provider of manufacturing and testing services for the pharma development market. As part of the deal, Penn Venture Partners and Life Sciences Greenhouse invested approximately $1.5 million in the combined company.
5 min read · 22 December 2009
3 min read · 22 December 2009
Limelight Networks Inc. (Nasdaq: LLNW) has agreed to acquire EyeWonder Inc., an Atlanta-based provider of leading provider of interactive digital advertising products and services. The deal is valued at approximately $110 million, including $62 million in cash and approximately 12.74 million shares of Limelight common stock. There also is an earn-out of 4.86 million additional shares based on financial milestones. EyeWonder raised an undisclosed amount of growth equity in 2007 from BIA Digital Partners.
5 min read · 22 December 2009